Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-09

Clinical Trial Update: Galactooligosaccharide (GOS) Supplementation and Calcium Absorption in Girls [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluated galactooligosaccharide (GOS) supplementation and calcium absorption in girls with osteoporosis; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcium (Calcium)
  • Galactooligosaccharide (GOS) (galactooligosaccharide)

Snippet

Sponsor: Purdue University | Conditions: Osteoporosis | EARLY_Phase 1 | Status: COMPLETED